İSMAİL BAL

Mr. İSMAİL BAL

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2025 in Gels
Verified
Journal Article
Open access
PDF file
İBİSMAİL BAL
İSMAİL BAL
MMMeltem Macit
Meltem Macit
AAAli S. Alasiri
Ali S. Alasiri
Onur Cem NamliOnur Cem Namli
Onur Cem Namli
Muhammad Sohail ArshadMuhammad Sohail Arshad
Muhammad Sohail Arshad
ISRAFIL KUCUKISRAFIL KUCUK
ISRAFIL KUCUK
In the present study, we developed a moxifloxacin (MXF)-encapsulated liposome-enriched alginate nanocomposite hydrogel coating. MXF was encapsulated in soy lecithin (SL:MXF:2:1) via the probe sonication method with an average efficiency of 80%. Two different manufacturing methods, including a micropipetting and a T-shaped microfluidic junction (TMJ) device technique, were used to incorporate the MXF-encapsulated liposomes into hydrogel matrices and layered as a coating on polymeric substrate material. Drug encapsulation and its incorporation into the hydrogel matrix significantly enhanced its stability and facilitated a prolonged drug release profile. A relatively rapid drug release was observed in the MXF-encapsulated liposome-loaded polymeric particulate layer developed via the micropipetting than the TMJ device technique. The findings confirmed sustained drug release behavior due to a hydrogel particulate structural uniformity conferred by the micromachine device, TMJ. Thus, these nanocomposite hydrogel coatings achieved can serve as a promising candidate for the treatment of ophthalmic or mucosal membrane infections.

24 February 2022
Verified
Book Chapter
Closed access
PDF file
İBİSMAİL BAL
İSMAİL BAL
IKIsrafil Kucuk
Israfil Kucuk
Drug delivery into the eye is always difficult when considering the other organs and tissues. An eye is a well-protected organ by defense mechanisms including various complex structures. These barriers, which protect the eye against foreign molecules or pathogens, also prevent drug-active substances through the eye. The vast majority of conventional treatment methods are suffering from low bioavailability (i.e., rapid clearance or low penetration into tissues). Recent developments in biomedical fields ensure promising alternatives to overcome these problems. Biodegradable polymers in ocular(ophthalmic) formulations exhibit improved residence time and mucoadhesion properties. Nanotechnology advancements have the potential to revolutionize the biomedical industry. Nano-scaled drug delivery systems help to increase bioavailability by allowing the effective dose to reach deeper tissues. Additionally, the development of metal-organic framework (MOF)-based materials is exciting and has all the properties it needs to be used in biomedical applications. It has been modified to be used in drug delivery systems, including ocular systems, thanks to its adjustable pore size and high drug loading capacity. This chapter describes using of polymers and MOF-based structures in ocular applications.